sai parenteral

New Delhi, April 2 Shares of Sai Parenteral, a diversified pharmaceutical formulation company, closed on Thursday with a premium of nearly 4 per cent against the issue price of Rs 392.The stock made its market debut at Rs 405, up 3.32 per cent from the issue price on the BSE. During the day...

New Delhi, April 2 Shares of Sai Parenteral, a diversified pharmaceutical formulation company, listed on Thursday with a premium of over 3 per cent against the issue price of Rs 392.The stock made its market debut at Rs 405, up 3.32 per cent from the issue price on the BSE.On the NSE, the...

New Delhi, March 27 The initial public offering (IPO) of Sai Parenteral, a diversified pharmaceutical formulation company, was fully subscribed on the final day of bidding on Friday, thanks to investments from institutional investors.The IPO received bids for 78,80,972 shares, compared to the...

New Delhi, March 24 The initial public offering of Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, received 4% subscription on the first day of bidding on Tuesday.According to NSE data, the IPO received bids for 3,35,350 shares against 75,22,486 shares on offer.The...

New Delhi, March 23 Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, raised over Rs 122 crore from anchor investors on Monday, a day before its initial public offering (IPO) opens for subscription.Morgan Stanley Asia (Singapore) Pte Ltd, Kotak Lifesciences Fund, Quant...